Mindera Health™ is commercializing scalable extraction technology and data analysis to report a patient’s individual transcriptomic data. Mindera’s technology creates Dermal Intelligence™, actionable information for payers, providers and patients. The company’s flagship test, Mind.Px, uses both a dermal biomarker patch and Machine Learning to determine a patient’s receptivity to very expensive psoriasis biologics. This information is valuable to payers, who can save thousands of dollars per biologic patient using Mind.Px at the outset of prescription. Mind.Px is the first test in a large planned product pipeline, including psoriatic arthritis and eczema biologic receptivity.
Total raised: $14M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.08.2024 | - | $14M | - |
Mentions in press and media 5
| Date | Title | Description |
| 02.08.2024 | Mindera Health's $14 Million Boost: A New Dawn for Psoriasis Treatment | In the world of dermatology, innovation often feels like a distant star. But with the recent $14 million funding secured by Mindera Health, that star is now within reach. This San Diego-based company is on a mission to transform psoriasis t... |
| 01.08.2024 | Mindera Health Closes $14M Convertible Note Financing | Mindera Health, Inc., a San Diego, CA-based company developing and commercializing next-generation medical technology to enable a new era of skin analytics at the molecular level, closed a $14M convertible note financing. The round was led ... |
| 31.07.2024 | Mindera Health Secures $14 Million to Advance Commercialization of First and Only Psoriasis Precision Medicine Test | San Diego, CA, July 31, 2024 (GLOBE NEWSWIRE) -- Mindera Health Inc. announces the closing of a $14M convertible note financing, led by Mountain Group Partners and other existing investors in anticipation of a Series B financing in 2025. Pr... |
| 31.07.2024 | Mindera Health Secures $14M to Advance Commercialization of Psoriasis Precision Medicine Test | What You Should Know: – Mindera Health, a leading developer of precision medicine solutions for dermatology, raises $14M convertible note financing led by Mountain Group Partners. – The funding will accelerate the commercialization of Minde... |
| - | Mindera Health | “Mindera Health – Shaping the Era of Digital Predictive Skin Analytics ” |